Cancer scandal: accused of dirty businesses with terminal

Cancer scandal: accused of dirty businesses with terminal






An earlier version of this text appeared in 2023 when the public prosecutor’s investigation against Alanta Health Group had been going on for several years. He was updated on the occasion of the charges that have now taken place. The presumption of innocence continues to apply to the accused of the Alanta network.

It was “not my idea,” writes Dr. M. a manager of the group in an email. “I was only allowed to arrange it and explain it to the patient.” By “it” he means his own prescriptions of medication for cancer. The oncologist is the specialist – he obviously didn’t have the last word. Did he fall his medical decisions for the benefit of his patients or in the business interest of the group? Did he even feel bound to this business interest?

In the past, M. worked as a resident doctor, but he was employed at the time in question-at the Hamburg Alanta Group, a group of companies that majority belongs to an investor based in London. And apparently he didn’t feel completely free in his decisions.

Because “I have always had doubts about” that the therapy is not influenced on the therapy, “writes Dr. in the past 6 months,” writes Dr. M. formulated somewhat quarried, he apparently wants to express it: According to his impression, it is very influenced on the therapy. The manager cannot like such statements.

The Alanta Health Group Group is now a case for the Hamburg Regional Court. After one of the most spectacular search actions in the history of the German healthcare system, six actors from the group will soon have to answer in front of the Commerce Court of the Hamburg District Court – including two pharmacists and four people employed in managing or managing people in their companies.

The group leaders are suspected of having manipulated the prescription process of the most expensive medication for seriously ill people in a sophisticated manner.

It is about commercial and gang-based fraud in 340 cases, according to the press release from the Hamburg General Prosecutor’s Office. The potential financial damage to the insured community would be gigantic if the court would follow the charges: “Unable to settle drugs” are said to have been submitted to statutory health insurance companies and have given them “due to payments of over 75 million euros”.

In addition, the accused is accused of having bound unfairly in 37 cases “by granting advantages in the prescription of medicinal products”. The Alanta Health Group Group’s network rejects the public prosecutor’s allegations in a press release.

Published in Stern 30/2023

Source: Stern

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts